Catalyst Wire Dossier Catalyst Wire Dossier

apatinib and etoposide capsule

· Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for apatinib and etoposide capsule, covering 2019-10-08 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer [Phase 3]

See pricing